Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for PROCEPT BioRobotics Corporation (PRCT : NSDQ)
 
 • Company Description   
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Number of Employees: 756

 
 • Price / Volume Information   
Yesterday's Closing Price: $58.18 Daily Weekly Monthly
20 Day Moving Average: 759,490 shares
Shares Outstanding: 55.33 (millions)
Market Capitalization: $3,219.02 (millions)
Beta: 1.07
52 Week High: $103.81
52 Week Low: $47.04
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.60% -9.49%
12 Week 6.40% -6.76%
Year To Date -27.75% -31.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
150 Baytech Drive
-
San Jose,CA 95134
USA
ph: 650-232-7200
fax: -
ir@procept-biorobotics.com http://www.procept-biorobotics.com
 
 • General Corporate Information   
Officers
Reza Zadno - President; Chief Executive Officer and Director
Thomas M. Prescott - Director and Chairman of the Board
Antal Desai - Director
Amy Dodrill - Director
Mary Garrett - Director

Peer Information
PROCEPT BioRobotics Corporation (ABMD)
PROCEPT BioRobotics Corporation (DMDS)
PROCEPT BioRobotics Corporation (CPWY.)
PROCEPT BioRobotics Corporation (EQUR)
PROCEPT BioRobotics Corporation (ECIA)
PROCEPT BioRobotics Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74276L105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 55.33
Most Recent Split Date: (:1)
Beta: 1.07
Market Capitalization: $3,219.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.49 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 22.01% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 8.27
Price/Cash Flow: -
Price / Sales: 12.92
EPS Growth
vs. Year Ago Period: 11.76%
vs. Previous Quarter: -28.57%
Sales Growth
vs. Year Ago Period: 55.28%
vs. Previous Quarter: 1.36%
ROE
06/30/25 - -
03/31/25 - -28.09
12/31/24 - -31.54
ROA
06/30/25 - -
03/31/25 - -20.02
12/31/24 - -21.96
Current Ratio
06/30/25 - -
03/31/25 - 8.95
12/31/24 - 9.07
Quick Ratio
06/30/25 - -
03/31/25 - 7.75
12/31/24 - 8.01
Operating Margin
06/30/25 - -
03/31/25 - -36.20
12/31/24 - -40.72
Net Margin
06/30/25 - -
03/31/25 - -36.20
12/31/24 - -40.72
Pre-Tax Margin
06/30/25 - -
03/31/25 - -36.20
12/31/24 - -40.72
Book Value
06/30/25 - -
03/31/25 - 7.03
12/31/24 - 7.71
Inventory Turnover
06/30/25 - -
03/31/25 - 1.74
12/31/24 - 1.82
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.13
12/31/24 - 0.13
Debt-to-Capital
06/30/25 - -
03/31/25 - 11.69
12/31/24 - 11.35
 

Powered by Zacks Investment Research ©